Sharpe & Dohme Ergot of Rye

Excerpts from The Physiological and Therapeutical Action of Ergot by Etienne Evetzky (1882)

"Ergot was admitted into the London Pharmacopoeia in 1836. Then a thorough study of its physiological action was entered upon, and as the work progressed the field of the therapeutic usefulness of ergot was extended; but the latter did not keep pace with the former, and , even at the present day, although we posses the essential knowledge of its physiological action, we greatly underestimate its therapeutic value..." (p. 10)

"As the main feature of the physiological action of ergot is stimulation of the motor centers of the organic muscular tissue, its therapeutic uses must be intimately related with the morbid conditions of the organs composed of this tissue, or with those that can be relieved by acting on these organs...

In view of the exceedingly varied and numerous therapeutic uses of ergot, to facilitate this description it is well to place all similiar conditions together and thus form a number of groups bearing their own distinct clinical type. Accordingly we have:

1. Disorders of the circulatoin, and diseases of the organs of circulation.
2. Paretic conditions of the organs composed of organic muscular tissue, the circulatory system excepted.
3. Inflammatory and other morbid enlargements and growths.
4. Abnormal secretions.
5. Symptoms referable to the nervous system, and depending chiefly upon the circulary disorders within it. " (pp. 53-54)

Want to learn more about ergot? Find information about Ergot Claviceps Pupurea and ergot derivatives.

Sharp & Dohme Ergot of Rye
Ergot of Rye
Ergot of Rye